Advanced search
Publication Cover
Expert Review of Respiratory Medicine Volume 4, 2010 - Issue 6
Submit an article Journal homepage
262
Views
83
CrossRef citations to date
0
Altmetric
Review

Viral infection and aging as cofactors for the development of pulmonary fibrosis

Payal K Naik Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI 48109-2200, USA; Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI 48109-2200, USA
&
Bethany B Moore Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI 48109-2200, USA; Department of Microbiology and Immunology, University of Michigan, 4053 BSRB, 109 Zina Pitcher Place, Ann Arbor, MI 48109-2200, USA. [email protected]; Department of Microbiology and Immunology, University of Michigan, 4053 BSRB, 109 Zina Pitcher Place, Ann Arbor, MI 48109-2200, USA. [email protected]
Pages 759-771 | Published online: 09 Jan 2014

Citations (83)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Kah Man Lai & Wai Leng Lee. (2022) The roles of epidermal growth factor receptor in viral infections. Growth Factors 40:1-2, pages 46-72.
Read now
Chiara Scelfo, Matteo Fontana, Eleonora Casalini, Francesco Menzella, Roberto Piro, Alessandro Zerbini, Lucia Spaggiari, Luca Ghidorsi, Giulia Ghidoni & Nicola C Facciolongo. (2020) A Dangerous Consequence of the Recent Pandemic: Early Lung Fibrosis Following COVID-19 Pneumonia – Case Reports. Therapeutics and Clinical Risk Management 16, pages 1039-1046.
Read now

Articles from other publishers (81)

Dalia D. Hadi, Mohammed Dheyaa Marsool Marsool, Ali Dheyaa Marsool Marsool, Neel Vora, Sajjad G. Al‐Badri, Nabeel H. K. Al‐Fatlawi, Ameer F. Abbas Al Wssawi, Abdullah M. T. Al‐Ibraheem, Khadija A. Hamza, Priyadarshi Prajjwal, Mohammed A. Mateen & Omniat Amir. (2023) Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension. Immunity, Inflammation and Disease 11:11.
Crossref
Nuria Mendoza, Sandra Casas-Recasens, Núria Olvera, Fernanda Hernandez-Gonzalez, Tamara Cruz, Núria Albacar, Xavier Alsina-Restoy, Alejandro Frino-Garcia, Gemma López-Saiz, Lucas Robres, Mauricio Rojas, Alvar Agustí, Jacobo Sellarés & Rosa Faner. (2023) Blood Immunophenotypes of Idiopathic Pulmonary Fibrosis: Relationship with Disease Severity and Progression. International Journal of Molecular Sciences 24:18, pages 13832.
Crossref
Stefan Lassan, Tomas Tesar, Jana Tisonova & Monika Lassanova. (2023) Pharmacological approaches to pulmonary fibrosis following COVID-19. Frontiers in Pharmacology 14.
Crossref
Amal A. Mohamed, Aya A. Nour, Noha M. Mosbah, Alaa S. M. Wahba, Omnia E. Esmail, Basem Eysa, Ahmed Heiba, Hussin H. Samir, Ahmed A. El-Kassas, Ahmed S. Adroase, Ahmed Y. Elamir, Ghada M. Mahmoud, Rasha S. Rafaat, Hatem A. Hassan & Yasmine S. El Abd. (2023) Evaluation of circulating insulin-like growth factor-1, heart-type fatty acid-binding protein, and endotrophin levels as prognostic markers of COVID-19 infection severity. Virology Journal 20:1.
Crossref
Thomas Antony, K. Vishak Acharya, B. Unnikrishnan & N.S. Keerthi. (2023) A silent march-Post covid fibrosis in asymptomatics – A cause for concern?. Indian Journal of Tuberculosis 70:2, pages 249-252.
Crossref
Joseph V. PergolizziJr.Jr., Jo Ann LeQuang, Marco Varrassi, Frank Breve, Peter Magnusson & Giustino Varrassi. (2023) What Do We Need to Know About Rising Rates of Idiopathic Pulmonary Fibrosis? A Narrative Review and Update. Advances in Therapy 40:4, pages 1334-1346.
Crossref
Dorottya Fesu, Lorinc Polivka, Eniko Barczi, Marcell Foldesi, Gabor Horvath, Edit Hidvegi, Aniko Bohacs & Veronika Muller. (2023) Post-COVID interstitial lung disease in symptomatic patients after COVID-19 disease. Inflammopharmacology 31:2, pages 565-571.
Crossref
Viviana Falcón-Cama, Teresita Montero-González, Emilio F. Acosta-Medina, Gerardo Guillen-Nieto, Jorge Berlanga-Acosta, Celia Fernández-Ortega, Anabel Alfonso-Falcón, Nathalie Gilva-Rodríguez, Lilianne López-Nocedo, Daina Cremata-García, Mariuska Matos-Terrero, Giselle Pentón-Rol, Iris Valdés, Leonardo Oramas-Díaz, Anamarys Suarez-Batista, Enrique Noa-Romero, Otto Cruz-Sui, Daisy Sánchez, Amanda I. Borrego-Díaz, Juan E. Valdés-Carreras, Ananayla Vizcaino, José Suárez-Alba, Rodolfo Valdés-Véliz, Gretchen Bergado, Miguel A. González, Tays Hernandez, Rydell Alvarez-Arzola, Anna C. Ramírez-Suárez, Dionne Casillas-Casanova, Gilda Lemos-Pérez, Omar R. Blanco-Águila, Angelina Díaz, Yorexis González, Mónica Bequet-Romero, Javier Marín-Prida, Julio C. Hernández-Perera, Leticia del Rosario-Cruz, Alina P. Marin-Díaz, Maritza González-Bravo, Israel Borrajero & Nelson Acosta-Rivero. (2023) Evidence of SARS-CoV-2 infection in postmortem lung, kidney, and liver samples, revealing cellular targets involved in COVID-19 pathogenesis. Archives of Virology 168:3.
Crossref
Hong-Rui ChenMei XueHao ZhouYao-Gong WuYan ChenWan-Xin Chen. (2023) Candida parapsilosis infection after double-lung transplantation in a patient with pulmonary fibrosis caused by COVID-19 . Cytojournal 20, pages 4.
Crossref
Ainur Tauekelova, Zhanar Kalila, Akerke Bakhtiyar, Zarina Sautbayeva, Polina Len, Aliya Sailybayeva, Sadyk Khamitov, Nazira Kadroldinova, Natasha Barteneva & Makhabbat Bekbossynova. (2023) Association of Lung Fibrotic Changes and Cardiological Dysfunction with Comorbidities in Long COVID-19 Cohort. International Journal of Environmental Research and Public Health 20:3, pages 2567.
Crossref
Getaneh Baye Mulu, Bantalem Tilaye Atinafu, Fetene Nigussie Tarekegn, Tigist Demssew Adane & Worku Misganaw Kebede. (2023) The Global Prevalence of Pulmonary Fibrosis Among Post–COVID-19 Follow-up Patients. Infectious Diseases in Clinical Practice 31:1.
Crossref
Mohsen Moghoofei, Shayan Mostafaei, Nasim Kondori, Michelle E. Armstrong & Farhad Babaei. (2022) Bacterial and viral coinfection in idiopathic pulmonary fibrosis patients: the prevalence and possible role in disease progression. BMC Pulmonary Medicine 22:1.
Crossref
George S. Stoyanov, Dimo Stoyanov, Martin Ivanov, Anton B. Tonchev, Hristo Popov & Lilyana Petkova. (2022) COVID-19-Associated Encephalopathy (COVEP): Basic Aspects of Neuropathology. Encyclopedia 2:4, pages 1773-1789.
Crossref
Sachin M. Patil. 2022. Idiopathic Pulmonary Fibrosis. Idiopathic Pulmonary Fibrosis.
Inhan Lee, Joohae Kim, Yohwan Yeo, Ji Yeon Lee, Ina Jeong, Joon-Sung Joh, Gayeon Kim, Bum Sik Chin, Yeonjae Kim, Min-Kyung Kim, Jaehyun Jeon, Yup Yoon, Sung Chan Jin & Junghyun Kim. (2022) Prognostic Factors for Pulmonary Fibrosis Following Pneumonia in Patients with COVID-19: A Prospective Study. Journal of Clinical Medicine 11:19, pages 5913.
Crossref
Maham Jehangir, Palmi Shah, Kavitha Yaddanapudi, Guang Shing Cheng & Sudhakar Pipavath. (2022) Imaging Viral Pneumonias. Advances in Clinical Radiology 4:1, pages 59-71.
Crossref
Natalia Fouz-Rosón, Ana Dolores Romero-Ortiz, Beatriz María Jiménez-Rodríguez, Ángela López-Bauzá, José Antonio Rodríguez-Portal, Zulema Palacios-Hidalgo, Marta Ferrer-Galván, Patricia Guerrero-Zamora, María Pérez Morales & Manuela Expósito-Ruiz. (2022) Infectious Exacerbations of Idiopathic Pulmonary Fibrosis. Archivos de Bronconeumología 58:7, pages 566-568.
Crossref
Alexandra Paul, Sachin Kumar, Tamer S. Kaoud, Madison R. Pickett, Amanda L. Bohanon, Janet Zoldan, Kevin N. Dalby & Sapun H. Parekh. (2022) Biomechanical Dependence of SARS-CoV-2 Infections. ACS Applied Bio Materials 5:5, pages 2307-2315.
Crossref
Wen Shi, Jiatong Hao, Yanliang Wu, Chang Liu, Kuniyoshi Shimizu, Renshi Li & Chaofeng Zhang. (2022) Protective effects of heterophyllin B against bleomycin-induced pulmonary fibrosis in mice via AMPK activation. European Journal of Pharmacology 921, pages 174825.
Crossref
Yuchao Ma, Chang Feng, Haibo Tang, Peizhi Deng, Yalan Li, Jie Wang, Shaihong Zhu & Liyong Zhu. (2022) Management of BMI Is a Potential New Approach for the Prevention of Idiopathic Pulmonary Fibrosis. Frontiers in Genetics 13.
Crossref
Mahbub Hasan, Nidhan Chandra Paul, Shamrat Kumar Paul, Abu Saim Mohammad Saikat, Hafeza Akter, Manoj Mandal & Sang-Suk Lee. (2022) Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis. Molecules 27:5, pages 1481.
Crossref
Mahshid Saleh, Seyedeh Zahra Fotook Kiaei & Maria Kavianpour. (2022) Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis. Stem Cell Research & Therapy 13:1.
Crossref
Shereen Farghaly, Mohammed Badedi, Rehab Ibrahim, Murad H. Sadhan, Aymn AlamoudiAwaji Alnami & Abdulrahman Muhajir. (2022) Clinical characteristics and outcomes of post-COVID-19 pulmonary fibrosis. Medicine 101:3, pages e28639.
Crossref
Esra Laloglu & Handan Alay. (2022) Role of transforming growth factor-beta 1 and connective tissue growth factor levels in coronavirus disease-2019-related lung Injury: a prospective, observational, cohort study. Revista da Sociedade Brasileira de Medicina Tropical 55.
Crossref
George S Stoyanov, Nevena Yanulova, Lyuben Stoev, Nedyalka Zgurova, Viktoriya Mihaylova, Deyan L Dzhenkov, Martina Stoeva, Nadezhda Stefanova, Kalin Kalchev & Lilyana Petkova. (2021) Temporal Patterns of COVID-19-Associated Pulmonary Pathology: An Autopsy Study. Cureus.
Crossref
T. I. Kalenchic, S L. Kabak & I. V. Korenevskaya. (2021) Pulmonary fibrosis as an outcome of COVID-19 pneumonia. Proceedings of the National Academy of Sciences of Belarus, Medical series 18:4, pages 413-421.
Crossref
Daniel Wendisch, Oliver Dietrich, Tommaso Mari, Saskia von Stillfried, Ignacio L. Ibarra, Mirja Mittermaier, Christin Mache, Robert Lorenz Chua, Rainer Knoll, Sara Timm, Sophia Brumhard, Tobias Krammer, Henrik Zauber, Anna Luisa Hiller, Anna Pascual-Reguant, Ronja Mothes, Roman David Bülow, Jessica Schulze, Alexander M. Leipold, Sonja Djudjaj, Florian Erhard, Robert Geffers, Fabian Pott, Julia Kazmierski, Josefine Radke, Panagiotis Pergantis, Kevin Baßler, Claudia Conrad, Anna C. Aschenbrenner, Birgit Sawitzki, Markus Landthaler, Emanuel Wyler, David Horst, Stefan Hippenstiel, Andreas Hocke, Frank L. Heppner, Alexander Uhrig, Carmen Garcia, Felix Machleidt, Susanne Herold, Sefer Elezkurtaj, Charlotte Thibeault, Martin Witzenrath, Clément Cochain, Norbert Suttorp, Christian Drosten, Christine Goffinet, Florian Kurth, Joachim L. Schultze, Helena Radbruch, Matthias Ochs, Roland Eils, Holger Müller-Redetzky, Anja E. Hauser, Malte D. Luecken, Fabian J. Theis, Christian Conrad, Thorsten Wolff, Peter Boor, Matthias Selbach, Antoine-Emmanuel Saliba & Leif Erik Sander. (2021) SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell 184:26, pages 6243-6261.e27.
Crossref
Kexiong Zhang, Lu Xu & Yu-Sheng Cong. (2021) Telomere Dysfunction in Idiopathic Pulmonary Fibrosis. Frontiers in Medicine 8.
Crossref
Xiang Tong, Shijie Zhang, Dongguang Wang, Li Zhang, Jizheng Huang, Tianli Zhang & Hong Fan. (2021) Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2. Frontiers in Pharmacology 12.
Crossref
Joshua J. Solomon, Brooke Heyman, Jane P. KoRany CondosDavid A. Lynch. (2021) CT of Post-Acute Lung Complications of COVID-19. Radiology 301:2, pages E383-E395.
Crossref
Fatmah Al‐Habeeb, Noof Aloufi, Hussein Traboulsi, Xingxing Liu, Parameswaran Nair, Christina Haston, Ilan Azuelos, Steven K. Huang, Eric S. White, Imed E. Gallouzi, Sergio Di Marco, David H. Eidelman & Carolyn J. Baglole. (2021) Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production. Journal of Cellular Physiology 236:10, pages 6836-6851.
Crossref
Johannes Scherr. (2021) Pathophysiologie von COVID-19 und deren mögliche Bedeutung für Long-COVID. Sports Orthopaedics and Traumatology 37:3, pages 205-213.
Crossref
D. L. Kellogg3rd3rd, D. L. KelloggJrJr, N. Musi & A. M. Nambiar. (2021) Cellular Senescence in Idiopathic Pulmonary Fibrosis. Current Molecular Biology Reports 7:3, pages 31-40.
Crossref
Timothy S. Blackwell, Justin C. Hewlett, Wendi R. Mason, Susan Martin, James Del Greco, Guixiao Ding, Pingsheng Wu, Lisa H. Lancaster, James E. Loyd, Rosemarie B. Dudenhofer, Margaret L. Salisbury & Jonathan A. Kropski. (2021) A Phase I Randomized, Controlled, Clinical Trial of Valganciclovir in Idiopathic Pulmonary Fibrosis. Annals of the American Thoracic Society 18:8, pages 1291-1297.
Crossref
Alison E. John, Chitra Joseph, Gisli Jenkins & Amanda L. Tatler. (2021) COVID‐19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts. Immunological Reviews 302:1, pages 228-240.
Crossref
Shiva Rattan Ambardar, Stephanie L. Hightower, Nikhil A. Huprikar, Kevin K. Chung, Anju Singhal & Jacob F. Collen. (2021) Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic. Journal of Clinical Medicine 10:11, pages 2452.
Crossref
Jing Qu, Shan-Zhong Yang, Yi Zhu, Ting Guo, Victor J. Thannickal & Yong Zhou. (2021) Targeting mechanosensitive MDM4 promotes lung fibrosis resolution in aged mice. Journal of Experimental Medicine 218:5.
Crossref
Penny Tremayne & Samuel John Clark. (2021) Idiopathic pulmonary fibrosis: a more common condition than you may think. British Journal of Nursing 30:6, pages 359-366.
Crossref
Laurens J Ceulemans, Jan Van Slambrouck, Paul De Leyn, Herbert Decaluwé, Hans Van Veer, Lieven Depypere, Vincent Ceuterick, Stijn E Verleden, Arno Vanstapel, Stefanie Desmet, Piet Maes, Marc Van Ranst, Piet Lormans, Geert Meyfroidt, Arne P Neyrinck, Bart M Vanaudenaerde, Eric Van Wijngaerden, Saskia Bos, Laurent Godinas, Peter Carmeliet, Geert M Verleden, Dirk E Van Raemdonck & Robin Vos. (2021) Successful double-lung transplantation from a donor previously infected with SARS-CoV-2. The Lancet Respiratory Medicine 9:3, pages 315-318.
Crossref
Lindsay T. McDonald. (2021) Healing after COVID-19: are survivors at risk for pulmonary fibrosis?. American Journal of Physiology-Lung Cellular and Molecular Physiology 320:2, pages L257-L265.
Crossref
Özge Yanık, Banu Hoşal, Alper Tekeli & Hilal Nalcı. (2019) Viral nucleic acid analysis with PCR in lacrimal tissue and nasal swab samples of primary acquired nasolacrimal duct obstruction cases. European Journal of Ophthalmology 31:1, pages 138-143.
Crossref
Irina G. Luzina, Erik P. Lillehoj, Virginia Lockatell, Sang W. Hyun, Katerina N. Lugkey, Akihiro Imamura, Hideharu Ishida, Christopher W. Cairo, Sergei P. Atamas & Simeon E. Goldblum. (2021) Therapeutic Effect of Neuraminidase-1–Selective Inhibition in Mouse Models of Bleomycin-Induced Pulmonary Inflammation and Fibrosis. Journal of Pharmacology and Experimental Therapeutics 376:1, pages 136-146.
Crossref
Mousa Ahmad Alhiyari, Fateen Ata, Mohd Islam Alghizzawi, Ammara Bint I Bilal, Ahmad Salih Abdulhadi & Zohaib Yousaf. (2021) Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection. IDCases 23, pages e01041.
Crossref
Antonio Vitiello & Francesco Ferrara. (2021) Physiopathology and prospectives for therapeutic treatment of pulmonary fibrotic state in COVID-19 patients. Current Research in Pharmacology and Drug Discovery 2, pages 100056.
Crossref
Antonio Vitiello, Chiara Pelliccia & Francesco Ferrara. (2020) COVID-19 Patients with Pulmonary Fibrotic Tissue: Clinical Pharmacological Rational of Antifibrotic Therapy. SN Comprehensive Clinical Medicine 2:10, pages 1709-1712.
Crossref
Taner BAYRAKTAROĞLU, Faruk KUTLUTÜRK & Sakin TEKİN. (2020) “COVID-19 Pandemisi ve Obezite” Prognozu: İki Pandemiden Ne Öğrendik?. Turkish Journal of Diabetes and Obesity 4:2, pages 138-146.
Crossref
Ilja L. Kruglikov & Philipp E. Scherer. (2020) The Role of Adipocytes and Adipocyte‐Like Cells in the Severity of COVID‐19 Infections. Obesity 28:7, pages 1187-1190.
Crossref
Kacper Lechowicz, Sylwester Drożdżal, Filip Machaj, Jakub Rosik, Bartosz Szostak, Małgorzata Zegan-Barańska, Jowita Biernawska, Wojciech Dabrowski, Iwona Rotter & Katarzyna Kotfis. (2020) COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection. Journal of Clinical Medicine 9:6, pages 1917.
Crossref
Gaohong Sheng, Peng Chen, Yanqiu Wei, Huihui Yue, Jiaojiao Chu, Jianping Zhao, Yihua Wang, Wanguang Zhang & Hui-Lan Zhang. (2020) Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis. Chest 157:5, pages 1175-1187.
Crossref
Zheng Wang, Shaohua Wang, Nick P. GoplenChaofan LiIn Su CheonQigang Dai, Su HuangJinjun Shan, Chaoyu MaZhenqing YeMin XiangAndrew H. LimperEva-Carmona PorqueraJacob E. Kohlmeier, Mark H. Kaplan, Nu Zhang, Aaron J. Johnson, Robert Vassallo & Jie Sun. (2019) PD-1 hi CD8 + resident memory T cells balance immunity and fibrotic sequelae . Science Immunology 4:36.
Crossref
Tobias Stoeger & Heiko Adler. (2019) “Novel” Triggers of Herpesvirus Reactivation and Their Potential Health Relevance. Frontiers in Microbiology 9.
Crossref
Nathan Sandbo. 2019. Idiopathic Pulmonary Fibrosis. Idiopathic Pulmonary Fibrosis 133 182 .
Carissa L. Patete, R. L. Toonkel & Marilyn Glassberg. 2019. Stem Cell-Based Therapy for Lung Disease. Stem Cell-Based Therapy for Lung Disease 119 130 .
Ying-ying Liu, Yao Shi, Ya Liu, Xing-hua Pan & Ke-xiong Zhang. (2018) Telomere shortening activates TGF-β/Smads signaling in lungs and enhances both lipopolysaccharide and bleomycin-induced pulmonary fibrosis. Acta Pharmacologica Sinica 39:11, pages 1735-1745.
Crossref
Justin C. Hewlett, Jonathan A. Kropski & Timothy S. Blackwell. (2018) Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets. Matrix Biology 71-72, pages 112-127.
Crossref
Sinead M. Walsh & Anthony W. O’Regan. (2018) Diffuse Parenchymal Lung Diseases in the Elderly. Current Geriatrics Reports 7:3, pages 174-180.
Crossref
Cecilia López-Ramírez, Lionel Suarez Valdivia & Jose Rodríguez Portal. (2018) Causes of Pulmonary Fibrosis in the Elderly. Medical Sciences 6:3, pages 58.
Crossref
Jun Tashiro, Gustavo A. Rubio, Andrew H. Limper, Kurt Williams, Sharon J. Elliot, Ioanna Ninou, Vassilis Aidinis, Argyrios Tzouvelekis & Marilyn K. Glassberg. (2017) Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis. Frontiers in Medicine 4.
Crossref
Ioanna Giopanou, Kristina A.M. Arendt & Georgios T. Stathopoulos. (2017) Lung carcinogenesis and fibrosis taken together. Current Opinion in Pulmonary Medicine 23:4, pages 290-297.
Crossref
Thiagarajan Venkataraman & Matthew B. Frieman. (2017) The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Antiviral Research 143, pages 142-150.
Crossref
Shanna L. Ashley, Meng Xia, Susan Murray, David N. O’Dwyer, Ethan Grant, Eric S. White, Kevin R. Flaherty, Fernando J. Martinez & Bethany B. Moore. (2016) Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF. PLOS ONE 11:8, pages e0159878.
Crossref
Jeffrey C. Horowitz, John J. Osterholzer, Antonia Marazioti & Georgios T. Stathopoulos. (2016) “Scar-cinoma”: viewing the fibrotic lung mesenchymal cell in the context of cancer biology. European Respiratory Journal 47:6, pages 1842-1854.
Crossref
C. Robalo Cordeiro, P. Campos, L. Carvalho, S. Campainha, S. Clemente, L. Figueiredo, J.M. Jesus, A. Marques, C. Souto-Moura, R. Pinto Basto, A. Ribeiro, M. Serrado & A. Morais. (2016) Consensus document for the diagnosis and treatment of idiopathic pulmonary fibrosis. Revista Portuguesa de Pneumologia (English Edition) 22:2, pages 112-122.
Crossref
Hidehiro Watanabe. 2016. Idiopathic Pulmonary Fibrosis. Idiopathic Pulmonary Fibrosis 133 144 .
Brigid M. O’Flaherty, Caline G. Matar, Brian S. Wakeman, AnaPatricia Garcia, Carol A. Wilke, Cynthia L. Courtney, Bethany B. Moore & Samuel H. Speck. (2015) CD8+ T Cell Response to Gammaherpesvirus Infection Mediates Inflammation and Fibrosis in Interferon Gamma Receptor-Deficient Mice. PLOS ONE 10:8, pages e0135719.
Crossref
S. Knippenberg, B. Ueberberg, R. Maus, J. Bohling, N. Ding, M. Tort Tarres, H.-G. Hoymann, D. Jonigk, N. Izykowski, J. C. Paton, A. D. Ogunniyi, S. Lindig, M. Bauer, T. Welte, W. Seeger, A. Guenther, T. H. Sisson, J. Gauldie, M. Kolb & U. A. Maus. (2015) Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin. Thorax 70:7, pages 636-646.
Crossref
Jonathan A. Kropski, Jason M. Pritchett, Donald F. Zoz, Peter F. Crossno, Cheryl Markin, Errine T. Garnett, Amber L. Degryse, Daphne B. Mitchell, Vasiliy V. Polosukhin, Otis B. Rickman, Leena Choi, Dong-Sheng Cheng, Melinda E. McConaha, Brittany R. Jones, Linda A. Gleaves, Frank B. McMahon, John A. Worrell, Joseph F. Solus, Lorraine B. Ware, Jae Woo Lee, Pierre P. Massion, Rinat Zaynagetdinov, Eric S. White, Jonathan D. Kurtis, Joyce E. Johnson, Steve D. Groshong, Lisa H. Lancaster, Lisa R. Young, Mark P. Steele, John A. Phillips III, Joy D. Cogan, James E. Loyd, William E. Lawson & Timothy S. Blackwell. (2015) Extensive Phenotyping of Individuals at Risk for Familial Interstitial Pneumonia Reveals Clues to the Pathogenesis of Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine 191:4, pages 417-426.
Crossref
Bethany B. Moore, Chris Fry, Yueren Zhou, Susan Murray, MeiLan K. Han, Fernando J. Martinez & Kevin R. Flaherty. (2014) Inflammatory Leukocyte Phenotypes Correlate with Disease Progression in Idiopathic Pulmonary Fibrosis. Frontiers in Medicine 1.
Crossref
Shanna L. AshleyYangjin JegalThomas A. MooreLinda F. van Dyk, Yasmina Laouar & Bethany B. Moore. (2014) γ-Herpes virus-68, but not Pseudomonas aeruginosa or influenza A (H1N1), exacerbates established murine lung fibrosis . American Journal of Physiology-Lung Cellular and Molecular Physiology 307:3, pages L219-L230.
Crossref
Mariana Kasabova, Alix Joulin‐Giet, Fabien Lecaille, Ahlame Saidi, Sylvain Marchand‐Adam & Gilles Lalmanach. (2013) Human cystatin C : A new biomarker of idiopathic pulmonary fibrosis? . PROTEOMICS – Clinical Applications 8:5-6, pages 447-453.
Crossref
Ivan O. Rosas, Paul F. Dellaripa, David J. Lederer, Dinesh Khanna, Lisa R. Young & Fernando J. Martinez. (2014) Interstitial Lung Disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Annals of the American Thoracic Society 11:Supplement 3, pages S169-S177.
Crossref
K. J. Williams. (2014) Gammaherpesviruses and Pulmonary Fibrosis. Veterinary Pathology 51:2, pages 372-384.
Crossref
Nathan Sandbo. 2014. Idiopathic Pulmonary Fibrosis. Idiopathic Pulmonary Fibrosis 161 205 .
David N. O’Dwyer, Michelle E. Armstrong, Glenda Trujillo, Gordon Cooke, Michael P. Keane, Padraic G. Fallon, A. John Simpson, Ann B. Millar, Emmet E. McGrath, Moira K. Whyte, Nik Hirani, Cory M. Hogaboam & Seamas C. Donnelly. (2013) The Toll-like Receptor 3 L412F Polymorphism and Disease Progression in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine 188:12, pages 1442-1450.
Crossref
B. Bartling. (2013) Cellular senescence in normal and premature lung agingZelluläre Seneszenz bei normaler und verfrühter Lungenalterung. Zeitschrift für Gerontologie und Geriatrie 46:7, pages 613-622.
Crossref
Jun Araya, Hiromichi Hara & Kazuyoshi Kuwano. (2013) Autophagy in the Pathogenesis of Pulmonary Disease. Internal Medicine 52:20, pages 2295-2303.
Crossref
Jun ArayaJun KojimaNaoki TakasakaSaburo ItoSatoko FujiiHiromichi HaraHaruhiko YanagisawaKenji KobayashiChikako TsurushigeMakoto KawaishiNoriki KamiyaJun HiranoMakoto OdakaToshiaki MorikawaStephen L. Nishimura, Yoshinori KawabataHiroshi HanoKatsutoshi NakayamaKazuyoshi Kuwano. (2013) Insufficient autophagy in idiopathic pulmonary fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology 304:1, pages L56-L69.
Crossref
Paul W. Noble, Christina E. Barkauskas & Dianhua Jiang. (2012) Pulmonary fibrosis: patterns and perpetrators. Journal of Clinical Investigation 122:8, pages 2756-2762.
Crossref
Harikrishna TanjoreTimothy S. Blackwell & William E. Lawson. (2012) Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology 302:8, pages L721-L729.
Crossref
Jonathan A. KropskiWilliam E. Lawson & Timothy S. Blackwell. (2012) Right place, right time: the evolving role of herpesvirus infection as a “second hit” in idiopathic pulmonary fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology 302:5, pages L441-L444.
Crossref
Daniela Damjanovic, Maziar Divangahi, Kapilan Kugathasan, Cherrie-Lee Small, Anna Zganiacz, Earl G. Brown, Cory M. Hogaboam, Jack Gauldie & Zhou Xing. (2011) Negative Regulation of Lung Inflammation and Immunopathology by TNF-α during Acute Influenza Infection. The American Journal of Pathology 179:6, pages 2963-2976.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.